Where should I publish my paper?
Paste your title, abstract or keywords. The finder matches them to research topics and suggests ranked journals that publish most on those topics.
Journals for “Immune Response and Inflammation”
Suggested journals
Topic match is relative to the best match in this search (100% = best). Under each journal, "Publishes on" shows which of the matched topics it publishes and what share of its recent papers they make up. Fees are shown only where DOAJ records them; "Not recorded" does not mean the journal is free.
| # | Journal | Topic match | ITS Journal Score | Global rank | Papers 2021–2025 | Open access | Fee (APC) | Compare |
|---|---|---|---|---|---|---|---|---|
| 1 | Inflammation Springer Science+Business Media · The Netherlands Publishes on: Immune Response and Inflammation (23%) | 100% | 80.4 | #2,017 | 1,002 | 50% | Not recorded | |
| 2 | Journal of Innate Immunity Karger Publishers · Switzerland · DOAJ Publishes on: Immune Response and Inflammation (23%) | 99% | 72.7 | #5,272 | 221 | 100% | 3,490 CHF | |
| 3 | Journal of Inflammation BioMed Central · United Kingdom · DOAJ Publishes on: Immune Response and Inflammation (21%) | 93% | 74.4 | #4,383 | 216 | 100% | 2,390 GBP | |
| 4 | Developmental & Comparative Immunology Elsevier BV · United Kingdom Publishes on: Immune Response and Inflammation (19%) | 82% | 74.7 | #4,242 | 1,168 | 19% | Not recorded | |
| 5 | Nature Immunology Nature Portfolio · United States Publishes on: Immune Response and Inflammation (14%) | 62% | 94.3 | #57 | 1,522 | 53% | Not recorded | |
| 6 | Immunopharmacology and Immunotoxicology Taylor & Francis · United States Publishes on: Immune Response and Inflammation (16%) | 72% | 70.7 | #6,349 | 459 | 19% | Not recorded | |
| 7 | Immunobiology Elsevier BV · Germany · DOAJ Publishes on: Immune Response and Inflammation (16%) | 70% | 73.1 | #5,094 | 901 | 51% | US$2,900 | |
| 8 | Immunity Cell Press · United States Publishes on: Immune Response and Inflammation (13%) | 56% | 96.5 | #23 | 1,212 | 93% | Not recorded | |
| 9 | International Immunopharmacology Elsevier BV · The Netherlands Publishes on: Immune Response and Inflammation (13%) | 58% | 86.1 | #661 | 8,040 | 24% | Not recorded | |
| 10 | BMC Immunology BioMed Central · United Kingdom · DOAJ Publishes on: Immune Response and Inflammation (13%) | 59% | 73.0 | #5,139 | 395 | 100% | 2,790 EUR | |
| 11 | International Journal of Inflammation Hindawi Publishing Corporation · United Kingdom · DOAJ Publishes on: Immune Response and Inflammation (15%) | 66% | 50.8 | #18,946 | 62 | 100% | US$1,100 | |
| 12 | Innate Immunity SAGE Publishing · United Kingdom · DOAJ Publishes on: Immune Response and Inflammation (13%) | 58% | 66.0 | #9,234 | 118 | 100% | US$2,650 | |
| 13 | Mucosal Immunology Elsevier BV · United States Publishes on: Immune Response and Inflammation (10%) | 46% | 81.5 | #1,666 | 536 | 97% | Not recorded | |
| 14 | Archivum Immunologiae et Therapiae Experimentalis Springer Science+Business Media · Switzerland Publishes on: Immune Response and Inflammation (11%) | 48% | 74.6 | #4,323 | 142 | 84% | Not recorded | |
| 15 | Central European Journal of Immunology Termedia Publishing House · Poland · DOAJ Publishes on: Immune Response and Inflammation (12%) | 54% | 62.0 | #11,644 | 259 | 100% | 700 EUR | |
| 16 | Nature reviews. Immunology Nature Portfolio · United Kingdom Publishes on: Immune Response and Inflammation (8%) | 34% | 95.6 | #33 | 768 | 36% | Not recorded | |
| 17 | Cytokine & Growth Factor Reviews Elsevier BV · United Kingdom Publishes on: Immune Response and Inflammation (9%) | 39% | 86.7 | #584 | 309 | 42% | Not recorded | |
| 18 | Progress in inflammation research Publishes on: Immune Response and Inflammation (14%) | 63% | 38.2 | #30,368 | 77 | 3% | Not recorded | |
| 19 | Seminars in Immunopathology Springer Science+Business Media · Germany Publishes on: Immune Response and Inflammation (8%) | 37% | 85.6 | #731 | 232 | 77% | Not recorded | |
| 20 | Cellular and Molecular Immunology Springer Nature · China Publishes on: Immune Response and Inflammation (7%) | 33% | 91.9 | #143 | 778 | 98% | Not recorded | |
| 21 | Trends in Immunology Elsevier BV · United Kingdom Publishes on: Immune Response and Inflammation (8%) | 35% | 85.6 | #740 | 681 | 52% | Not recorded | |
| 22 | Immunological Investigations Taylor & Francis · United States Publishes on: Immune Response and Inflammation (10%) | 43% | 69.0 | #7,389 | 362 | 24% | Not recorded | |
| 23 | Immunity Inflammation and Disease Wiley · United Kingdom · DOAJ Publishes on: Immune Response and Inflammation (9%) | 40% | 75.1 | #4,075 | 1,321 | 100% | US$3,400 | |
| 24 | American Journal of BioMedicine United States Publishes on: Immune Response and Inflammation (14%) | 60% | 37.5 | #31,059 | 80 | 75% | Not recorded | |
| 25 | Inflammation and Regeneration BioMed Central · United Kingdom · DOAJ Publishes on: Immune Response and Inflammation (9%) | 38% | 76.1 | #3,630 | 249 | 100% | Not recorded | |
| 26 | Journal of Immunology Research Hindawi Publishing Corporation · United Kingdom · DOAJ Publishes on: Immune Response and Inflammation (8%) | 37% | 76.1 | #3,647 | 1,058 | 100% | US$3,110 | |
| 27 | Immune Network Korean Association of Immunobiologists · South Korea Publishes on: Immune Response and Inflammation (8%) | 35% | 77.8 | #2,967 | 231 | 100% | Not recorded | |
| 28 | ImmunoHorizons Oxford University Press · United States · DOAJ Publishes on: Immune Response and Inflammation (10%) | 42% | 64.7 | #9,996 | 393 | 100% | US$1,595 | |
| 29 | Journal of Inflammation Research Dove Medical Press · New Zealand · DOAJ Publishes on: Immune Response and Inflammation (7%) | 33% | 79.6 | #2,302 | 3,471 | 100% | US$4,320 | |
| 30 | Current Medical Science Springer Science+Business Media · Switzerland Publishes on: Immune Response and Inflammation (9%) | 38% | 69.1 | #7,319 | 727 | 17% | Not recorded |
Before you submit
Use this list as a shortlist, not a decision. For each journal, read its aims and scope and a few recent articles, check its peer-review and fee policy on its own website, and confirm any indexing (Scopus, Web of Science, PubMed) with the indexer itself. Be careful with journals that promise very fast acceptance or that contact you by email asking for papers.
How the ITS Journal Score works
One formula applies to every ranked journal, using open data from OpenAlex: 45% citation impact, 35% h-index and 20% size (papers published 2021–2025). Citation impact is the smaller of the journal's two-year mean citedness and its five-year citations per paper, so a journal whose output collapsed cannot jump to the top on old citations. Each part is half a percentile and half a log-scaled value, so the very top is still separated. Growth and open-access share are shown separately and are not part of the score.
A journal is ranked only if it published at least 50 papers in 2021–2025 and was active in at least five of the last six years. Field rankings compare a journal only with journals in the same field; the field is the OpenAlex field with most of the journal's recent papers, or "Multidisciplinary" when no field has 30% of them.
What this is not: the ITS Journal Score is not a Journal Impact Factor, CiteScore or SJR, and this site does not say whether a journal is indexed in Scopus, Web of Science or PubMed. Always confirm aims and scope, indexing, peer review and fees on the journal's own website before you submit.